ipilimumab,nivolumab
bms
['nivo', '/ipi', 'sclc', 'energy', 'nsclc', 'lcsm,(-blcsm)']
including the excluded: data from phase 3 energy study of 1l nivo/ipi v chemo in older adult ( 70 yr) or ps 2 pts w/ mnsclc #asco22 highlights the feasibility of studies dedicated to a patient population that is often underrepresented in key #lcsm clinical trials! 
Chief Heme/Onc Education Fellow @MDAndersonNews | Alum of @dukeu @muschealth @vumchealth | Interest in #meded ??#cancer #lcsm | Tweets my own ? medical advice